Genenta Science S.p.A. rose 18.8% on Tuesday, November 3, 2026, on 249,270 shares, 2.9 times its average daily volume. The headline around the move:
Genenta Science S.p.A. (GNTA:NASDAQ) closed at $0.985 on November 3, 2026, up 18.82% on the day. The stock trades 61.8% below its 52-week high of $2.58 and 79.1% above its 52-week low of $0.550. Genenta Science S.p.A. is part of the Health Care sector.
In 252 trading sessions since November 20, 2025, GNTA closed higher on 101 days (40%). Its best day was June 1, 2026 (+60.19%) and its worst was November 4, 2026 (-28.93%). The stock moved 10% or more in a single session 34 times. It opened at least 5% above the previous day's high 10 times.
Genenta Science SPA is a clinical-stage biotechnology company pioneering the development of lentivirus-based first-in-class gene and cell therapies in cancer.
Find more stocks like GNTA with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.